Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the FLT3 Mutation Detection Test is 7 days.

What are the prerequisites for the test FLT3 Mutation Detection Test

  • Patients must have a suspected diagnosis of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
  • Patients must have a bone marrow or blood sample available for testing
  • Patients must not have received a bone marrow transplant within the past 6 months
  • Patients must have a signed consent form for the test

What are the measure values for the test FLT3 Mutation Detection Test

  • Sensitivity: 98%
  • Specificity: 99%
  • Positive Predictive Value: 97%
  • Negative Predictive Value: 99%

What does this test FLT3 Mutation Detection Test identify?

  • The FLT3 Mutation Detection Test is used to identify mutations in the FLT3 gene.
  • FLT3 mutations are commonly found in patients with acute myeloid leukemia (AML) and are associated with a poor prognosis.
  • Identifying these mutations can help guide treatment decisions and predict patient outcomes.
  • The test can detect both internal tandem duplications (ITDs) and point mutations in the FLT3 gene.
  • Results from the FLT3 Mutation Detection Test can inform personalized treatment plans and monitor response to therapy.

Why is this test FLT3 Mutation Detection Test taken?

The FLT3 Mutation Detection Test is taken to detect mutations in the FLT3 gene. This gene produces a protein that helps regulate the growth and division of blood cells. Mutations in the FLT3 gene are often found in patients with certain types of blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

Identifying mutations in the FLT3 gene can help doctors determine the best course of treatment for patients with these types of blood cancers. Patients with FLT3 mutations may be eligible for targeted therapies that specifically target the mutated protein, leading to more effective and personalized treatment options.

No FAQs available.

Customer Google Rating